In cancer, numerous studies have demonstrated that Bregs facilitate tumor immune evasion by secreting IL-10 and TGF-β and expressing PD-L1, thereby suppressing cytotoxic T and NK cell activity and contributing to tumor progression. This evidence concerns the gene IL10 and neoplasm.